Printer Friendly

Articles from JCNN News Summaries (July 4, 2006)

1-4 out of 4 article(s)
Title Author Type Words
Asahi Kasei Pharma, CoTherix Conclude Licensing Agreement for Fasudil, Rho-kinase Inhibitor. 140
Nippon Kayaku Seeking Additional Approval for Its Antitumor Agent. 92
SPARX Capital Partners Aqcuire NILE'S Communications Shares. 182
Takara Bio, Okayama University Jointly Confirm That Angelica Utilis Promotes Bone Formation and Increases Bone Mass. 122

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |